Bacterial vaginosis (BV) is an ecological imbalance of the vaginal microbiota affecting mostly women of reproductive age group. This study was carried out among 160 nonpregnant women registered at the Outpatient Department of Gynaecology/Obstetrics of KIST Medical College Teaching Hospital, Imadol, Lalitpur, Nepal, from November 2014 to May 2015. The aim of the study was to assess the association of the risk factors with BV and analyze the type of bacteria associated with BV. Nugent's scoring method was used for diagnosis of BV in this study. The overall prevalence of BV was 24.4% among symptomatic patients. Douching was statistically related to BV (P = 0.015). Also, BV was significantly associated with consistency (P = 0.0001), odor (P = 0.02), and amount of abnormal vaginal discharge (P = 0.09). Contraceptives users on anatomical sites were found more prone to BV than those who did not use contraceptives on anatomical sites. Pseudomonas spp., Escherichia coli, Acinetobacter spp., Proteus spp., Klebsiella spp., Neisseria gonorrhoeae, Enterobacter spp., Citrobacter spp., Staphylococcus aureus, Coagulase-Negative Staphylococci (CoNS), and Streptococcus agalactiae were associated with BV and out of those Lactobacillus spp. was the predominant organism. The higher prevalence of BV among symptomatic patients indicates interventions should be applied to reduce the incidence of stillbirth, abortion, and sterility.
BackgroundMethicillin resistant Staphylococcus aureus (MRSA) has evolved as a serious threat to public health. It has capability to cause infections not only in health care settings but also in community. Due to the multidrug resistance shown by MRSA, there are limited treatment options for the infections caused by this superbug. Vancomycin is used as the drug of choice for the treatment of infections caused by MRSA. Different studies from all around the world have documented the emergence of strains of S. aureus those are intermediate sensitive or resistant to vancomycin. And recently, there have been reports of reduced susceptibility of MRSA to vancomycin, from Nepal also. So the main purpose of this study was to determine the minimum inhibitory concentration (MIC) of vancomycin to methicillin resistant S. aureus isolated from different clinical specimens.MethodsTotal 125 strains of S. aureus isolated from different clinical samples at KIST Medical College and Teaching Hospital, Lalitpur, Nepal from Nov 2012 to June 2013, were subjected to MRSA detection by cefoxitin disc diffusion method. The minimum inhibitory concentrations of vancomycin to confirmed MRSA strains were determined by agar dilution method. Yellow colored colonies in mannitol salt agar, which were gram positive cocci, catalase positive and coagulase positive were confirmed to be S. aureus.ResultsAmong, total 125 S. aureus strains isolated; 47(37.6%) were MRSA. Minimum inhibitory concentrations of vancomycin to the strains of MRSA ranged from 0.125 μg/ml to 1 μg/ml.ConclusionFrom our findings we concluded that the rate of isolation of MRSA among all the strains of S. aureus isolated from clinical samples was very high. However, none of the MRSA strains were found to be vancomycin intermediate-sensitive or vancomycin-resistant.
BackgroundIn developing countries like Nepal, 90% ethanol is cheap and is available in most hospitals. The unavailability of isopropyl alcohol (IPA) in these settings led us to compare the efficacy between 90% ethanol and isopropyl alcohol pads in reducing the bacterial contamination of diaphragm of stethoscope.MethodsA randomized blinded experimental study was carried out to determine the difference between cleaning stethoscopes with 90% ethanol and IPA. Cultures of diaphragm were taken before and after cleaning with one of the cleaning agent. Colony forming units (CFU) count and organism identification was done by a blinded investigator. CFU before and after cleaning were compared using Wilcoxon signed–rank test. Mann Whitney U test was used to compare the decrease in CFU count between the cleaning agents.ResultsAbout 30% of the stethoscopes harbored potential pathogens. Significant reduction in CFU was observed with both IPA (Wilcoxon signed–rank test, P value <0.001) and 90% ethanol (Wilcoxon signed–rank test, P value <0.001). Comparing median decrease in CFU between cleaning with IPA and with 90% ethanol, no significant difference was found (Mann Whitney U test; U = 1357, P value >0.05).ConclusionsBoth 90% ethanol and IPA are equally effective in decontaminating the diaphragm of stethoscope. Selection of agent should be done on the basis of cost and availability.
Antimicrobial resistance (AMR) is a global problem, and Nepal is no exception. Countries are expected to report annually to the World Health Organization on their AMR surveillance progress through a Global Antimicrobial Resistance Surveillance System, in which Nepal enrolled in 2017. We assessed the quality of AMR surveillance data during 2019–2020 at nine surveillance sites in Province 3 of Nepal for completeness, consistency, and timeliness and examined barriers for non-reporting sites. Here, we present the results of this cross-sectional descriptive study of secondary AMR data from five reporting sites and barriers identified through a structured questionnaire completed by representatives at the five reporting and four non-reporting sites. Among the 1584 records from the reporting sites assessed for consistency and completeness, 77–92% were consistent and 88–100% were complete, with inter-site variation. Data from two sites were received by the 15th day of the following month, whereas receipt was delayed by a mean of 175 days at three other sites. All four non-reporting sites lacked dedicated data personnel, and two lacked computers. The AMR surveillance data collection process needs improvement in completeness, consistency, and timeliness. Non-reporting sites need support to meet the specific requirements for data compilation and sharing.
Introduction: Lower respiratory tract infection is a common infection and accounts for a greaterburden of disease worldwide. It is a great challenge to the clinician and still more, with increasingantimicrobial resistance. Its empirical treatment may vary according to the type of causativeorganisms. The objective of this study is to identify the pathogenic microorganisms and theirantimicrobial susceptibility pattern from sputum sample. Methods: This descriptive cross-sectional study was conducted in KIST Medical College andTeaching Hospital from February 2015 to January 2016. Ethical approval was taken from institutionalreview committee prior to the study with reference no. 0051/2014/15. Data on culture and sensitivityof isolates from sputum samples were collected from the records of the hospital. Sample collection,processing, identification of microorganisms and antimicrobial susceptibility tests were performedaccording to the Clinical and Laboratory Standards Institute guidelines. All the data were tabulatedin an Excel sheet and analyzed using SPSS version 20. Results: Out of 2318 samples, 694 (29.93%) sputum samples at 95% confidence interval (737.21-650.79) were reported as culture positive. Klebsiella was the most common isolate followedby Pseudomonas, Escherichia coli, Acinetobacter, Staphylococcus aureus, Candida albicans,Streptococcus pneumoniae, Streptococcus pyogenes, and others. Imipenem and vancomycin showedthe most sensitivity towards gram-negative and gram-positive bacteria respectively. Conclusions: Proper diagnosis, identification of causative agents and their antimicrobial susceptibilitypattern are important steps to limit the irrational use of antimicrobials. Prescribing antimicrobialsempirically in the case of suspected lower respiratory tract infection is difficult.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.